Rafferty Asset Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.56M | Buy |
149,760
+50,655
| +51% | +$866K | 0.01% | 546 |
|
2025
Q1 | $6.32M | Sell |
99,105
-10,131
| -9% | -$647K | 0.03% | 322 |
|
2024
Q4 | $13.3M | Sell |
109,236
-28,806
| -21% | -$3.5M | 0.05% | 230 |
|
2024
Q3 | $17.2M | Sell |
138,042
-8,542
| -6% | -$1.07M | 0.06% | 171 |
|
2024
Q2 | $23.2M | Buy |
146,584
+72,845
| +99% | +$11.5M | 0.09% | 123 |
|
2024
Q1 | $9.55M | Sell |
73,739
-29,414
| -29% | -$3.81M | 0.04% | 279 |
|
2023
Q4 | $9.95M | Buy |
103,153
+28,973
| +39% | +$2.79M | 0.04% | 282 |
|
2023
Q3 | $8.99M | Buy |
74,180
+9,176
| +14% | +$1.11M | 0.05% | 250 |
|
2023
Q2 | $7.44M | Buy |
65,004
+16,358
| +34% | +$1.87M | 0.04% | 313 |
|
2023
Q1 | $6.7M | Sell |
48,646
-21,988
| -31% | -$3.03M | 0.05% | 306 |
|
2022
Q4 | $9.15M | Buy |
70,634
+9,803
| +16% | +$1.27M | 0.08% | 201 |
|
2022
Q3 | $6.72M | Buy |
60,831
+504
| +0.8% | +$55.7K | 0.07% | 234 |
|
2022
Q2 | $4.52M | Sell |
60,327
-13,566
| -18% | -$1.02M | 0.04% | 297 |
|
2022
Q1 | $5.77M | Buy |
73,893
+7,782
| +12% | +$608K | 0.03% | 347 |
|
2021
Q4 | $5.95M | Buy |
66,111
+21,752
| +49% | +$1.96M | 0.03% | 308 |
|
2021
Q3 | $4.1M | Buy |
44,359
+14,027
| +46% | +$1.3M | 0.03% | 350 |
|
2021
Q2 | $2.36M | Sell |
30,332
-8,192
| -21% | -$637K | 0.01% | 639 |
|
2021
Q1 | $2.87M | Buy |
38,524
+32,950
| +591% | +$2.46M | 0.02% | 521 |
|
2020
Q4 | $950K | Sell |
5,574
-9,607
| -63% | -$1.64M | 0.01% | 516 |
|
2020
Q3 | $2.13M | Buy |
15,181
+9,109
| +150% | +$1.28M | 0.03% | 397 |
|
2020
Q2 | $974K | Buy |
6,072
+2,482
| +69% | +$398K | 0.01% | 555 |
|
2020
Q1 | $351K | Sell |
3,590
-26,238
| -88% | -$2.57M | 0.01% | 403 |
|
2019
Q4 | $3.85M | Sell |
29,828
-45,686
| -61% | -$5.9M | 0.06% | 174 |
|
2019
Q3 | $5.69M | Buy |
75,514
+34,167
| +83% | +$2.57M | 0.09% | 139 |
|
2019
Q2 | $6.28M | Buy |
41,347
+3,433
| +9% | +$522K | 0.11% | 122 |
|
2019
Q1 | $4.52M | Buy |
+37,914
| New | +$4.52M | 0.07% | 154 |
|